Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin

Activated protein C (aPC) is an important feedback regulator of the clotting cascade. In vivo, the conversion of protein C (PC) from its zymogen to activated form is mediated primarily by thrombin bound to thrombomodulin (TM), an endothelial cell surface protein. Molecular modeling suggests residues...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry Vol. 271; no. 37; p. 22285
Main Authors: Gerlitz, B, Grinnell, B W
Format: Journal Article
Language:English
Published: United States 13.09.1996
Subjects:
ISSN:0021-9258
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Activated protein C (aPC) is an important feedback regulator of the clotting cascade. In vivo, the conversion of protein C (PC) from its zymogen to activated form is mediated primarily by thrombin bound to thrombomodulin (TM), an endothelial cell surface protein. Molecular modeling suggests residues Lys37-Lys38-Lys39 of protein C's serine protease domain reside in a surface-exposed loop (variable region 1) whose high concentration of positive charge might be involved in protein-protein interactions. In this study, we have examined the role of the conserved tribasic Lys37-39 charge center in human protein C activation. This sequence was changed to acidic by substitution with Asp37-Glu38-Asp39 (DED) and Glu37-Glu38-Glu39 (EEE), or to neutrality by substitution with Gly37-Gly38-Gly39 (GGG). These mutant PCs, expressed and purified from recombinant human 293 cells, appeared normal with regard to intracellular processing, ability to be secreted, and formation of a viable active site for tripeptidyl-p-nitroanilide substrate cleavage. For activation by free thrombin, wild-type (wt) and mutant PCs displayed equivalent activation rates, as well as identical calcium-dependent inhibition of such activation. Activation of wt-PC with a soluble TM-thrombin complex yielded a 2,000-fold faster rate compared with that by free thrombin at the same (physiological) calcium level. In contrast, the acidic mutants DED and EEE exhibited virtually no TM-mediated increase in activation rate, while the neutral mutant GGG was somewhat intermediate with a 30-fold stimulation of activation rate. These reductions in activation rate were independent of the presence of chondroitin sulfate on TM. Our observations represent the first identification of residues whose mutation essentially uncouples activation by the TM-thrombin complex without affecting activation by free thrombin. Further, our results suggest that VR1 residues within the zymogen form of a serine protease can be important for recognition by physiological activators.
AbstractList Activated protein C (aPC) is an important feedback regulator of the clotting cascade. In vivo, the conversion of protein C (PC) from its zymogen to activated form is mediated primarily by thrombin bound to thrombomodulin (TM), an endothelial cell surface protein. Molecular modeling suggests residues Lys37-Lys38-Lys39 of protein C's serine protease domain reside in a surface-exposed loop (variable region 1) whose high concentration of positive charge might be involved in protein-protein interactions. In this study, we have examined the role of the conserved tribasic Lys37-39 charge center in human protein C activation. This sequence was changed to acidic by substitution with Asp37-Glu38-Asp39 (DED) and Glu37-Glu38-Glu39 (EEE), or to neutrality by substitution with Gly37-Gly38-Gly39 (GGG). These mutant PCs, expressed and purified from recombinant human 293 cells, appeared normal with regard to intracellular processing, ability to be secreted, and formation of a viable active site for tripeptidyl-p-nitroanilide substrate cleavage. For activation by free thrombin, wild-type (wt) and mutant PCs displayed equivalent activation rates, as well as identical calcium-dependent inhibition of such activation. Activation of wt-PC with a soluble TM-thrombin complex yielded a 2,000-fold faster rate compared with that by free thrombin at the same (physiological) calcium level. In contrast, the acidic mutants DED and EEE exhibited virtually no TM-mediated increase in activation rate, while the neutral mutant GGG was somewhat intermediate with a 30-fold stimulation of activation rate. These reductions in activation rate were independent of the presence of chondroitin sulfate on TM. Our observations represent the first identification of residues whose mutation essentially uncouples activation by the TM-thrombin complex without affecting activation by free thrombin. Further, our results suggest that VR1 residues within the zymogen form of a serine protease can be important for recognition by physiological activators.Activated protein C (aPC) is an important feedback regulator of the clotting cascade. In vivo, the conversion of protein C (PC) from its zymogen to activated form is mediated primarily by thrombin bound to thrombomodulin (TM), an endothelial cell surface protein. Molecular modeling suggests residues Lys37-Lys38-Lys39 of protein C's serine protease domain reside in a surface-exposed loop (variable region 1) whose high concentration of positive charge might be involved in protein-protein interactions. In this study, we have examined the role of the conserved tribasic Lys37-39 charge center in human protein C activation. This sequence was changed to acidic by substitution with Asp37-Glu38-Asp39 (DED) and Glu37-Glu38-Glu39 (EEE), or to neutrality by substitution with Gly37-Gly38-Gly39 (GGG). These mutant PCs, expressed and purified from recombinant human 293 cells, appeared normal with regard to intracellular processing, ability to be secreted, and formation of a viable active site for tripeptidyl-p-nitroanilide substrate cleavage. For activation by free thrombin, wild-type (wt) and mutant PCs displayed equivalent activation rates, as well as identical calcium-dependent inhibition of such activation. Activation of wt-PC with a soluble TM-thrombin complex yielded a 2,000-fold faster rate compared with that by free thrombin at the same (physiological) calcium level. In contrast, the acidic mutants DED and EEE exhibited virtually no TM-mediated increase in activation rate, while the neutral mutant GGG was somewhat intermediate with a 30-fold stimulation of activation rate. These reductions in activation rate were independent of the presence of chondroitin sulfate on TM. Our observations represent the first identification of residues whose mutation essentially uncouples activation by the TM-thrombin complex without affecting activation by free thrombin. Further, our results suggest that VR1 residues within the zymogen form of a serine protease can be important for recognition by physiological activators.
Activated protein C (aPC) is an important feedback regulator of the clotting cascade. In vivo, the conversion of protein C (PC) from its zymogen to activated form is mediated primarily by thrombin bound to thrombomodulin (TM), an endothelial cell surface protein. Molecular modeling suggests residues Lys37-Lys38-Lys39 of protein C's serine protease domain reside in a surface-exposed loop (variable region 1) whose high concentration of positive charge might be involved in protein-protein interactions. In this study, we have examined the role of the conserved tribasic Lys37-39 charge center in human protein C activation. This sequence was changed to acidic by substitution with Asp37-Glu38-Asp39 (DED) and Glu37-Glu38-Glu39 (EEE), or to neutrality by substitution with Gly37-Gly38-Gly39 (GGG). These mutant PCs, expressed and purified from recombinant human 293 cells, appeared normal with regard to intracellular processing, ability to be secreted, and formation of a viable active site for tripeptidyl-p-nitroanilide substrate cleavage. For activation by free thrombin, wild-type (wt) and mutant PCs displayed equivalent activation rates, as well as identical calcium-dependent inhibition of such activation. Activation of wt-PC with a soluble TM-thrombin complex yielded a 2,000-fold faster rate compared with that by free thrombin at the same (physiological) calcium level. In contrast, the acidic mutants DED and EEE exhibited virtually no TM-mediated increase in activation rate, while the neutral mutant GGG was somewhat intermediate with a 30-fold stimulation of activation rate. These reductions in activation rate were independent of the presence of chondroitin sulfate on TM. Our observations represent the first identification of residues whose mutation essentially uncouples activation by the TM-thrombin complex without affecting activation by free thrombin. Further, our results suggest that VR1 residues within the zymogen form of a serine protease can be important for recognition by physiological activators.
Author Grinnell, B W
Gerlitz, B
Author_xml – sequence: 1
  givenname: B
  surname: Gerlitz
  fullname: Gerlitz, B
  organization: Department of Cardiovascular Research, Lilly Research Laboratories, Indianapolis, Indiana 46285-0444, USA
– sequence: 2
  givenname: B W
  surname: Grinnell
  fullname: Grinnell, B W
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8798383$$D View this record in MEDLINE/PubMed
BookMark eNpdUD1PwzAU9FBUWmBnQfLEluCPOI5HVPElFbHAHNmJTVwldokdoD-Jf4mllIUnPT3d6e6ke2uwcN5pAC4xyjHixc1ONTnhOKc8J4RUbAFWCBGcCcKqU7AOYYfSFAIvwbLioqIVXYGf5ynKaL2D3sD96KOWQcPWD9I6OOpg20kHuD0EyjMqYCK7aZBulia0SVRnlY0ByibazzlLHWDsdNrRD8oPvp1667IZJlPjh32vv-GXjZ2fIpTG6GR27_8yzKj_Qqw7BydG9kFfHO8ZeLu_e908ZtuXh6fN7TZrKOIsI4wXlRQ6IcaMKcpGpqcwTBTHbSMER0a0qigxx4iVjDWibClTBVGGVIiX5Axcz7mp4kcqH-vBhkb3vXTaT6HmFU1uSpLw6iic1KDbej_aQY6H-vhb8gu-Q36x
CitedBy_id crossref_primary_10_1016_S0006_3495_00_76530_1
crossref_primary_10_1021_bi015899r
crossref_primary_10_1073_pnas_0736918100
crossref_primary_10_1074_jbc_M211797200
crossref_primary_10_1016_S0167_4838_99_00266_6
crossref_primary_10_1097_MOH_0b013e32830abdf4
crossref_primary_10_1046_j_1538_7836_2003_00299_x
crossref_primary_10_1124_jpet_107_130609
crossref_primary_10_1074_jbc_M110_115337
crossref_primary_10_1002_prot_10627
crossref_primary_10_1111_jth_13275
crossref_primary_10_1182_blood_V91_12_4572
crossref_primary_10_1055_s_0043_1777133
crossref_primary_10_1074_jbc_M103138200
crossref_primary_10_1160_TH11_08_0522
crossref_primary_10_1002__SICI_1097_0134_19990501_35_2_218__AID_PROT8_3_0_CO_2_2
crossref_primary_10_1182_blood_V91_12_4572_412k13_4572_4580
crossref_primary_10_1038_35006683
crossref_primary_10_1074_jbc_274_41_29087
crossref_primary_10_1532_IJH97_03149
crossref_primary_10_1016_j_bcmd_2005_12_027
crossref_primary_10_1038_2906
crossref_primary_10_1016_S1570_9639_03_00164_X
crossref_primary_10_1038_nature06559
crossref_primary_10_1182_blood_2012_03_415323
crossref_primary_10_1161_01_ATV_0000168421_13467_82
crossref_primary_10_1038_s41598_020_68078_z
crossref_primary_10_1111_j_1538_7836_2009_03377_x
crossref_primary_10_1021_cr960135g
crossref_primary_10_1023_A_1011158717139
crossref_primary_10_1172_JCI74255
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1074/jbc.271.37.22285
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
ExternalDocumentID 8798383
Genre Journal Article
GroupedDBID ---
-DZ
-ET
-~X
.55
.GJ
0R~
186
18M
2WC
3O-
53G
5BI
5GY
5RE
5VS
6TJ
79B
85S
AAEDW
AAFWJ
AALRI
AARDX
AAXUO
AAYOK
ABDNZ
ABOCM
ABPPZ
ABRJW
ABTAH
ACGFO
ACNCT
ADBBV
ADIYS
ADVLN
AENEX
AEXQZ
AFFNX
AFOSN
AFPKN
AI.
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BTFSW
C1A
CGR
CJ0
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FA8
FDB
FRP
GROUPED_DOAJ
GX1
H13
HH5
IH2
J5H
KQ8
L7B
MVM
N9A
NHB
NPM
OHT
OK1
P-O
P0W
P2P
PKN
R.V
RHF
RHI
RNS
ROL
RPM
SJN
TBC
TN5
TR2
UHB
UPT
UQL
VH1
VQA
W8F
WH7
WHG
WOQ
X7M
XJT
XSW
Y6R
YQT
YSK
YWH
YYP
YZZ
Z5M
ZGI
ZY4
~02
~KM
.7T
7X8
AAYWO
ACVFH
ADCNI
ADXHL
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
ID FETCH-LOGICAL-c3075-25748a9ec3055ff46ca271512b71dc9970f9db4617105655c96d35b42bf280762
IEDL.DBID 7X8
ISSN 0021-9258
IngestDate Fri Sep 05 07:32:22 EDT 2025
Wed Feb 19 02:29:26 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 37
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3075-25748a9ec3055ff46ca271512b71dc9970f9db4617105655c96d35b42bf280762
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1074/jbc.271.37.22285
PMID 8798383
PQID 78346132
PQPubID 23479
ParticipantIDs proquest_miscellaneous_78346132
pubmed_primary_8798383
PublicationCentury 1900
PublicationDate 1996-Sep-13
PublicationDateYYYYMMDD 1996-09-13
PublicationDate_xml – month: 09
  year: 1996
  text: 1996-Sep-13
  day: 13
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of biological chemistry
PublicationTitleAlternate J Biol Chem
PublicationYear 1996
SSID ssj0000491
Score 1.5105407
Snippet Activated protein C (aPC) is an important feedback regulator of the clotting cascade. In vivo, the conversion of protein C (PC) from its zymogen to activated...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 22285
SubjectTerms Amino Acid Sequence
Calcium - metabolism
Electrophoresis, Polyacrylamide Gel
Enzyme Activation
Humans
Kinetics
Lysine - genetics
Lysine - metabolism
Molecular Sequence Data
Mutagenesis, Site-Directed
Protein Binding
Protein C - genetics
Protein C - metabolism
Sequence Homology, Amino Acid
Serine Endopeptidases - chemistry
Structure-Activity Relationship
Thrombin - metabolism
Thrombomodulin - metabolism
Title Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin
URI https://www.ncbi.nlm.nih.gov/pubmed/8798383
https://www.proquest.com/docview/78346132
Volume 271
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LaxsxEB7cptBckjRpiNM21SH0Jtu7Wq1WUCjGNOQQGx8S8M3osaJb8G7qR4h_Uv5lRpKXQKH0kItAYiUWaZj5NDOaD-ASB7VKmaGZtIxmhc6pzDSniWNWImC3WutANiEmk2I2k9MOfG_fwvi0ylYnBkVtG-N95H1PCIGmJ_1x_4d6zigfW90RaLyBPYZAxsu0mL3UCkfsG_nyfBJCyotdkBJtZv-3Nr1UJD0met4Dwv8NL4OZuTp83Q8ewcEOXpJhlIcP0CnrYzgZ1ni1XmzJNxISPoMn_Rjej1qytxN4Gm9iTJ40joTaDWjdiG0WqqoJ3sgri39CbrYrhspCEhwM5H7xU-yNcOhXpav1iviXEtHPS_SWIL4knophoZtFY33aO41dnBTS2ctH4n3BzWZNVMgtQVv61xpuWbaLVPVHuLv6eTu6pjsWB2pQf3CKOiErlCyNry3mXJYbhVuPOEOLxBopxcChRODWIdZBdMmNzC3jOku185V68vQU3tZNXZ4BYcLw0g2cTozIsFWKKZ07xxPlKdN5F762RzPH_fOhD1WXzWY1bw-nC6fxdOf3sZjHvBCywFv6-X-nfoL9mLEtacI-w55D9VB-gXfmYV2tlhdB9rCdTMfPi-3n9w
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mutation+of+protease+domain+residues+Lys37-39+in+human+protein+C+inhibits+activation+by+the+thrombomodulin-thrombin+complex+without+affecting+activation+by+free+thrombin&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Gerlitz%2C+B&rft.au=Grinnell%2C+B+W&rft.date=1996-09-13&rft.issn=0021-9258&rft.volume=271&rft.issue=37&rft.spage=22285&rft_id=info:doi/10.1074%2Fjbc.271.37.22285&rft_id=info%3Apmid%2F8798383&rft_id=info%3Apmid%2F8798383&rft.externalDocID=8798383
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon